Company intelligence / Profile preview
Torrent Pharmaceuticals Limited
- Ownership
- Public · TORNTPHARM
- Development stage
- Commercial
Overview
Torrent Pharmaceuticals has multiple approved drugs including Adalimumab biosimilar, Aspirin/Atorvastatin/Metoprolol Succinate/Ramipril, Darbepoetin alfa biosimilar, and Prasugrel Hydrochloride/Aspirin. They also have TRC-160334 in Phase 1 for Inflammatory Bowel Diseases.
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyDermatologyHematology
- Modalities
- Small molecule drugsBiosimilarsChemical drugsColony-stimulating factorsMonoclonal antibodies
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Torrent Pharmaceuticals Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Torrent Pharmaceuticals Limited.